Scaling Up MSC & EV Production In Bioreactors
Source: RoosterBio
The focus of this talk is the scale up of MSC and EV production in bioreactors. RoosterBio is made up of experts in hMSC manufacturing, and we have developed commercially relevant processes in 2D and 3D that enable our customers to develop MSC based therapeutics quickly and efficiently. A couple key highlights include: process scalability for successful commercialization of cell therapy products, higher quantity and quality EV production, and producing EVs with consistent characteristics recommended by ISEV guidelines. Companies should always begin to look at their process with the end goal in mind.
VIEW THE WEBINAR!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
RoosterBio
This website uses cookies to ensure you get the best experience on our website. Learn more